Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-18

Clinical Trial Update: Xeomin Cosmetic in the Management of Masseter [Phase 4]

View source ↗

Summary

Phase 4 trial of Xeomin Cosmetic for managing Masseter Muscle Hypertrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xeomin Cosmetic (botulinum toxin type A)

Snippet

Sponsor: Erevna Innovations Inc. | Conditions: Masseter Muscle Hypertrophy | Phase 4 | Status: COMPLETED